This Group of Stocks Is Soaring in 2026. Trump May Send Them Higher Still.

Rising geopolitical tensions and new policy commitments are driving a significant re-rating of the defense sector: the S&P Aerospace & Defense Select index is up ~11% YTD and the State Street SPDR S&P Aerospace & Defense ETF (XAR) is up ~10.5%, with Lockheed Martin (+26%), Northrop Grumman (+20%) and Huntington Ingalls (+24%) leading gains. NATO's goal was raised to 5% of GDP by 2035 (3.5% pure defense), Germany plans to double defense spending within five years, and global defense spending is forecast at $2.6 trillion this year (+8.1% vs. 2025) rising to $2.9 trillion by decade-end; large U.S. initiatives (Golden Dome, Golden Fleet) and recent $6.67B and $9B arms sales to Israel and Saudi Arabia respectively further bolster U.S. defense contractors' revenue outlook. These structural fiscal and geopolitical drivers suggest continued upside for defense names and sector ETFs, with material implications for portfolio positioning in aerospace & defense equities.

Analysis

Market structure: Defense primes (Lockheed LMT, Northrop NOC, Huntington Ingalls HII) are direct beneficiaries as multi-year government commitments (NATO 5% by 2035, Germany doubling by ~2030, US Golden Dome/Fleet) shift procurement budgets toward large, integrated contractors with program delivery capacity. Suppliers of specialty metals, mil-spec semiconductors and shipbuilding inputs will see demand spikes; commercial aerospace and nondefense capex competitors for supply/ labor will be squeezed, pressuring input inflation and lead times over 12–36 months.

Risk assessment: Tail risks include rapid geopolitical de-escalation or a change in US fiscal politics that trims defense budgets (low-probability but 30–50% P&L impact on program-dependent revenues), major program cancellations/ cost overruns, and supply-chain embargoes (chips/rare earths) that could compress margins. Immediate effects (days/weeks) are sentiment-driven rallies; medium-term (3–12 months) depends on formal budget approvals and arms-sale pipelines; long-term (2–10 years) favors primes with FMS footprints and shipbuilding capacity.

Trade implications: Expect better pricing power for prime contractors; gross-margin expansion likely if primes pass higher input costs into long-term contracts, but short-term volatility around awards and hearings will be high. Cross-asset: increased fiscal issuance implies upward pressure on 10y yields (+20–70bps over 12–24 months under plausible deficit scenarios), stronger USD vs EUR/EM (arms flows, rate differentials), and higher prices for steel, titanium and copper.

Contrarian angles: Consensus assumes sustained budgets — pricing likely to front-run fundamentals, creating opportunities to sell into rallies; smaller suppliers and niche contractors could be the bottleneck and underperform despite headline spending. Historical parallel: 2003–10 post-9/11 defense boom where primes outperformed but many mid-tier suppliers failed on execution; focus conviction on balance-sheet-strong primes with backlog visibility and FMS exposure.

Key Decisions for Investors

• Establish a 3% portfolio long position in LMT and a 2% long in NOC over the next 2–8 weeks (scale in 50% now, 50% on 10% pullback). Use a 12% trailing stop and target 30–50% upside over 12–24 months tied to NATO budget ratifications and major contract awards.
• Add a 1% position in HII (shipbuilding exposure) sized as a tactical growth play for Golden Fleet programs; prefer cash-secured puts 5–10% below current price with 3–6 month expiries to collect premium and set entry, or buy-to-open 12-month call spreads 15–25% OTM to limit premium outlay.
• Implement a pair trade: long LMT (1.5% of portfolio) vs short XAR (1.5%) to capture expected outperformance of prime integrators vs a crowded mid/small-cap defense basket; horizon 6–18 months, unwind on confirmed multi-year budget passes or if XAR outperforms primes by >12% in 30 days.
• Reduce duration exposure by 1–2 years (trim long-duration Treasuries by 2–3% of portfolio) and rotate 3–5% of equity allocation from consumer/cyclicals into A&D names; hedge FX risk on European defense suppliers by maintaining >50% EUR hedges if direct non-USD revenue exposure exceeds 10% of position value.